IP Library › Granted Patent US 12,577,569
Granted Patent B2
US 12,577,569 · App. 18/057,614 · Granted Mar 17, 2026

Aptamers for the reversible inhibition of DNA polymerases

Inventors: Susan Marie Rupp (Marion, IA); Shambhavi Shubham (Coralville, IA); Scott Rose (Coralville, IA); Brianna Cagle (Iowa City, IA)
Assignee: INTEGRATED DNA TECHNOLOGIES, INC.
C12N15/115C12Q1/6848C12Q1/686C12N2310/16
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,577,569
App. No.
18/057,614
Granted
Mar 17, 2026
Kind
B2
Abstract

Described herein are methods and compositions for improved polymerase chain reaction (PCR). In one aspect the methods and compositions include improved aptamers to reversibly inhibit polymerase and exonuclease activity of the polymerase enzyme.

Claims (27)

1 . A composition comprising:

a thermostable DNA polymerase and an aptamer;

wherein the aptamer is selected from a nucleotide sequence comprising at least 90% identity to SEQ ID NO:8 or SEQ ID NO:9.

2 . The composition of claim 1 , wherein the aptamer is selected from a nucleotide sequence comprising SEQ ID NO:8 or SEQ ID NO:9.

3 . The composition of claim 1 , wherein the thermostable DNA polymerase is a Phusion DNA polymerase.

4 . The composition of claim 2 wherein the Phusion DNA polymerase is Pfu-sso7d.

5 . An aptamer selected from a nucleotide sequence comprising at least 90% identity to SEQ ID NO:8 or SEQ ID NO:9.

6 . The aptamer of claim 5 , wherein the aptamer is selected from a nucleotide sequence comprising SEQ ID NO:8 or SEQ ID NO:9.

7 . A method for amplifying a target DNA sequence, said method comprising the steps of:

(a) providing a reaction mixture comprising:

(i) a thermostable DNA polymerase,

(ii) a thermostable DNA polymerase aptamer selected from a nucleotide sequence comprising at least 90% identity to SEQ ID NO:8 or SEQ ID NO: 9, wherein the thermostable DNA polymerase aptamer binds to the thermostable DNA polymerase to form a blocked thermostable DNA polymerase;

(iii) at least one oligonucleotide primer,

(iv) one or more sample nucleic acids that may or may not comprise a target sequence complementary to the at least one oligonucleotide primer;

(b) hybridizing the at least one oligonucleotide primer to the sample nucleic acids that comprise a target DNA sequence complementary to the at least one oligonucleotide primer;

(c) elevating the temperature to release the thermostable DNA polymerase aptamer from the blocked thermostable DNA polymerase; and

(d) initiating DNA polymerase activity and extending the primer with the DNA polymerase.

8 . The method of claim 7 , wherein the thermostable DNA polymerase aptamer is selected from a nucleotide sequence comprising SEQ ID NO:8 or SEQ ID NO:9.

9 . The method of claim 7 , wherein the thermostable DNA polymerase is a Phusion DNA polymerase.

10 . The method of claim 9 , wherein the Phusion DNA polymerase is Pfu-sso7d.

11 . The method of claim 7 , wherein the elevated temperature to release the thermostable DNA polymerase aptamer from the blocked thermostable DNA polymerase is greater than 45° C.

12 . The method of claim 7 , wherein the elevated temperature to release the thermostable DNA polymerase aptamer from the blocked thermostable DNA polymerase is from 50-55° C.

13 . The method of claim 7 , wherein the initiating DNA polymerase activity and extending the primer with the DNA polymerase is performed at a temperature of greater than 65° C.

14 . The method of claim 7 , wherein the reaction mixture further comprises, a buffer mixture and dNTPs.

15 . The method of claim 14 , wherein:

the buffer mixture comprises: 10 mM Tris-HCl (pH 8.4 at 25° C.), 1.5 mM MgCl 2 , 110 mM KCl, 0.08% (w/v) Brij-58, 0.2% (w/v) PEG-8000, and 0.1% (v/v) propylene glycol); and

the dNTPs comprise 0.8 mM dNTPs.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 24, 2024
From: RUPP, SUSAN MARIE; SHUBHAM, SHAMBHAVI; ROSE, SCOTT; CAGLE, BRIANNA
To: INTEGRATED DNA TECHNOLOGIES, INC.
Reel/Frame 066880/0369 →
Continuity (2)
Provisional Application 63281872 · Nov 22, 2021
Related Publication 20230102276A1 · Mar 30, 2023
References Cited (5)
US 10036061B2 · Fiss · 2018 [cited by examiner]
Smith, T. et al. “Comparison of biosequences.” Advances in applied mathematics 2.4 (1981): 482-489. [cited by applicant]
Wang, T., et al. “Three decades of nucleic acid aptamer technologies: Lessons learned, progress and opportunities on aptamer development.” Biotechnology advances 37.1 (2019): 28-50. [cited by applicant]
International Search Report and Written Opinion for Application No. PCT/US2022/080254 dated May 15, 2023 (12 pages). [cited by applicant]
Dang, C. et al. “Oligonucleotide inhibitors of Taq DNA polymerase facilitate detection of low copy number targets by PCR.” Journal of molecular biology 264.2 (1996): 268-278. [cited by applicant]